Alkem Laboratories, a company in the Pharmaceuticals industry, reported revenue of ₹4,552 crore and net profit of ₹667 crore for the September 2026 quarter.
Alkem Laboratories (NSE: ALKEM) closed at ₹5,185.00 on 20 Nov 2026, down 9.0% over the past year. Its market capitalisation is ₹61,994 crore and it trades at 28.7 times earnings.
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.